219 related articles for article (PubMed ID: 34669068)
1. MRI-derived proton density fat fraction.
Yoshizawa E; Yamada A
J Med Ultrason (2001); 2021 Oct; 48(4):497-506. PubMed ID: 34669068
[TBL] [Abstract][Full Text] [Related]
2. Deep Learning for Inference of Hepatic Proton Density Fat Fraction From T1-Weighted In-Phase and Opposed-Phase MRI: Retrospective Analysis of Population-Based Trial Data.
Wang K; Cunha GM; Hasenstab K; Henderson WC; Middleton MS; Cole SA; Umans JG; Ali T; Hsiao A; Sirlin CB
AJR Am J Roentgenol; 2023 Nov; 221(5):620-631. PubMed ID: 37466189
[No Abstract] [Full Text] [Related]
3. Multiparametric ultrasound imaging for early-stage steatosis: Comparison with magnetic resonance imaging-based proton density fat fraction.
Baek J; Basavarajappa L; Margolis R; Arthur L; Li J; Hoyt K; Parker KJ
Med Phys; 2024 Feb; 51(2):1313-1325. PubMed ID: 37503961
[TBL] [Abstract][Full Text] [Related]
4. Assessment of a high-SNR chemical-shift-encoded MRI with complex reconstruction for proton density fat fraction (PDFF) estimation overall and in the low-fat range.
Park CC; Hooker C; Hooker JC; Bass E; Haufe W; Schlein A; Covarrubias Y; Heba E; Bydder M; Wolfson T; Gamst A; Loomba R; Schwimmer J; Hernando D; Reeder SB; Middleton M; Sirlin CB; Hamilton G
J Magn Reson Imaging; 2019 Jan; 49(1):229-238. PubMed ID: 29707848
[TBL] [Abstract][Full Text] [Related]
5. A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease.
Idilman IS; Keskin O; Celik A; Savas B; Elhan AH; Idilman R; Karcaaltincaba M
Acta Radiol; 2016 Mar; 57(3):271-8. PubMed ID: 25855666
[TBL] [Abstract][Full Text] [Related]
6. Multiparametric MRI in Patients With Nonalcoholic Fatty Liver Disease.
Schaapman JJ; Tushuizen ME; Coenraad MJ; Lamb HJ
J Magn Reson Imaging; 2021 Jun; 53(6):1623-1631. PubMed ID: 32822095
[TBL] [Abstract][Full Text] [Related]
7. Diurnal Variation of Proton Density Fat Fraction in the Liver Using Quantitative Chemical Shift Encoded MRI.
Colgan TJ; Van Pay AJ; Sharma SD; Mao L; Reeder SB
J Magn Reson Imaging; 2020 Feb; 51(2):407-414. PubMed ID: 31168893
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Imaging Modalities Against Liver Biopsy in Nonalcoholic Fatty Liver Disease: The Amsterdam NAFLD-NASH Cohort.
Troelstra MA; Witjes JJ; van Dijk AM; Mak AL; Gurney-Champion O; Runge JH; Zwirs D; Stols-Gonçalves D; Zwinderman AH; Ten Wolde M; Monajemi H; Ramsoekh S; Sinkus R; van Delden OM; Beuers UH; Verheij J; Nieuwdorp M; Nederveen AJ; Holleboom AG
J Magn Reson Imaging; 2021 Dec; 54(6):1937-1949. PubMed ID: 33991378
[TBL] [Abstract][Full Text] [Related]
9. The Accuracy and Clinical Relevance of the Multi-echo Dixon Technique for Evaluating Changes to Hepatic Steatosis in Patients with Non-alcoholic Fatty Liver Disease Treated with Formulated Food.
Yang Y; Xu K; Chen X; Ding J; Shi J; Li J
Magn Reson Med Sci; 2023 Apr; 22(2):263-271. PubMed ID: 35676065
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of multi-echo Dixon sequence in quantification of hepatic steatosis in Chinese children and adolescents.
Zhao YZ; Gan YG; Zhou JL; Liu JQ; Cao WG; Cheng SM; Bai DM; Wang MZ; Gao FQ; Zhou SM
World J Gastroenterol; 2019 Mar; 25(12):1513-1523. PubMed ID: 30948914
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of proton density fat fraction (PDFF) obtained from a vendor-neutral MRI sequence and MRQuantif software.
Orcel T; Chau HT; Turlin B; Chaigneau J; Bannier E; Otal P; Frampas E; Leguen A; Boulic A; Saint-Jalmes H; Aubé C; Boursier J; Bardou-Jacquet E; Gandon Y
Eur Radiol; 2023 Dec; 33(12):8999-9009. PubMed ID: 37402003
[TBL] [Abstract][Full Text] [Related]
12. Free-breathing quantification of hepatic fat in healthy children and children with nonalcoholic fatty liver disease using a multi-echo 3-D stack-of-radial MRI technique.
Armstrong T; Ly KV; Murthy S; Ghahremani S; Kim GHJ; Calkins KL; Wu HH
Pediatr Radiol; 2018 Jul; 48(7):941-953. PubMed ID: 29728744
[TBL] [Abstract][Full Text] [Related]
13. Multiparametric MR assessment of liver fat, iron, and fibrosis: a concise overview of the liver "Triple Screen".
Low G; Ferguson C; Locas S; Tu W; Manolea F; Sam M; Wilson MP
Abdom Radiol (NY); 2023 Jun; 48(6):2060-2073. PubMed ID: 37041393
[TBL] [Abstract][Full Text] [Related]
14. Quantitative Ultrasound Radiofrequency Data Analysis for the Assessment of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Using Magnetic Resonance Imaging Proton Density Fat Fraction as the Reference Standard.
Jeon SK; Lee JM; Joo I; Park SJ
Korean J Radiol; 2021 Jul; 22(7):1077-1086. PubMed ID: 33739636
[TBL] [Abstract][Full Text] [Related]
15. Validation of a motion-robust 2D sequential technique for quantification of hepatic proton density fat fraction during free breathing.
Pooler BD; Hernando D; Ruby JA; Ishii H; Shimakawa A; Reeder SB
J Magn Reson Imaging; 2018 Dec; 48(6):1578-1585. PubMed ID: 29665193
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous quantification of hepatic MRI-PDFF and R2* in a rabbit model with nonalcoholic fatty liver disease.
Wang X; Zhang X; Ma L; Li S
Sci China Life Sci; 2018 Sep; 61(9):1107-1114. PubMed ID: 29934919
[TBL] [Abstract][Full Text] [Related]
17. Direct Comparison of Quantitative US versus Controlled Attenuation Parameter for Liver Fat Assessment Using MRI Proton Density Fat Fraction as the Reference Standard in Patients Suspected of Having NAFLD.
Jung J; Han A; Madamba E; Bettencourt R; Loomba RR; Boehringer AS; Andre MP; Erdman JW; O'Brien WD; Fowler KJ; Sirlin CB; Loomba R
Radiology; 2022 Jul; 304(1):75-82. PubMed ID: 35348378
[TBL] [Abstract][Full Text] [Related]
18. Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial.
Cui J; Philo L; Nguyen P; Hofflich H; Hernandez C; Bettencourt R; Richards L; Salotti J; Bhatt A; Hooker J; Haufe W; Hooker C; Brenner DA; Sirlin CB; Loomba R
J Hepatol; 2016 Aug; 65(2):369-76. PubMed ID: 27151177
[TBL] [Abstract][Full Text] [Related]
19. Can negligible hepatic steatosis determined by magnetic resonance imaging-proton density fat fraction obviate the need for liver biopsy in potential liver donors?
Satkunasingham J; Nik HH; Fischer S; Menezes R; Selzner N; Cattral M; Grant D; Jhaveri K
Liver Transpl; 2018 Apr; 24(4):470-477. PubMed ID: 29080242
[TBL] [Abstract][Full Text] [Related]
20. MRI-determined liver proton density fat fraction, with MRS validation: Comparison of regions of interest sampling methods in patients with type 2 diabetes.
Vu KN; Gilbert G; Chalut M; Chagnon M; Chartrand G; Tang A
J Magn Reson Imaging; 2016 May; 43(5):1090-9. PubMed ID: 26536609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]